Ex Marks the Spot AI Cracks the Code

The future starts here.
So cancer can end here.

Early and accurate detection of cancer starts here.
Exai Bio’s next-generation RNA-based platform delivers actionable insight into cancer biology from a simple blood draw.

Keep scrolling to learn
what makes our platform unique
An older couple celebrating their lives

Exai is revolutionizing how we diagnose, treat, and manage cancer.

Our Science
Using our novel RNA biomarkers, we found signals in what appeared to others as noise. With these biomarkers and AI, we have connected the dots, finding actionable clinical insights that weren't possible before.
Babak Alipanahi
Founder & Chief Scientific Officer
Close the cookie popup
Cookie Settings
By clicking "Accept All", you are agreeing to store cookies on your device to enhance your experience and help Exai's marketing.
Accept All
cookie settings